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Objective: Prognostic markers for pancreatic ductal adenocarcinoma (PDA) have failed to accurately
predict patient prognosis. Recently, interest has developed in the accuracy of integrin-associated PINCH
protein expression in human cancers as a predictive marker of tumour status. The goal of this study was
to define the expression of PINCH protein in PDA.
Methods: Human PDA samples and orthotopic tumours from a murine model were analysed by immu-
nohistochemistry for PINCH expression. In the animal model, PINCH expression was compared between
primary and metastatic tumours. In the human samples, PINCH expression was correlated with stage,
nodal involvement, margin status and overall survival.
Results: In the murine model, there was greater PINCH expression in metastatic tumours than in primary
tumours. In the human PDA samples, greater staining for PINCH in the tumour cells was correlated with
higher T status. Additionally, high PINCH expression in the stroma was associated with decreased overall
survival.
Conclusions: Findings of increased PINCH protein in more advanced stages of human PDA, as well as
in metastatic tumours in the animal model, support the hypothesis that PINCH is an important controller
of cell survival and migration. Additionally, the importance of the differential expression of PINCH in the
human tumour and stroma warrants further evaluation.
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Introduction
Pancreatic ductal adenocarcinoma (PDA) remains one of the
most poorly controlled solid organ malignancies in the USA and
is the fourth leading cause of cancer-related deaths.1 Surgical
resection remains the primary treatment. Yet, nearly 80% of
surgically resected patients with localized pancreatic cancer die
as a result of recurrent or metastatic disease.1 Additionally, the
pathologic positive margin rate at resection remains 50–75%.
These outcomes imply a particularly invasive tumour phenotype.
Recent studies have suggested an important role for the inter-
action of tumour cells and tumour-associated stroma cells in
the regulation of cell–cell adhesion and invasion.2,3 The adhesion
of cells to the extracellular matrix (ECM) is essential for cell
migration, division and cell–cell signalling.4,5 Variations in this
interaction between the tumour and surrounding tissues may
facilitate the survival, malignant transformation and invasion of
tumour cells.3,6–9 Integrin-associated proteins facilitate this ab-
normal signalling and control.4,5,9 PINCH, a particularly interest-
ing new cysteine-histidine-rich integrin-associated protein, is an
important component of the focal adhesion complexes that link
the ECM to the support structures within the cell and is expressed
in many human tissues. PINCH expression has been shown to be
upregulated in many malignant tissues, including breast, colon,
prostate, lung and oral squamous cell carcinomas.10–12 In these
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tumours PINCH expression localizes to the peri-tumoral stroma
cells, particularly at the tumour’s invasive edges. Additionally,
PINCH expression is correlated with poorer patient prognosis in
colon and oral epithelial cancers.10,12 The aggressive nature and
strong desmoplastic response in PDA implies that PINCH expres-
sion may be an important outcome marker for PDA and may
identify which patients are more likely to experience recurrence.
The purpose of this study was to investigate the expression of
PINCH in PDA and to determine the association between PINCH
expression and tumour aggressiveness or patient prognosis.
We initially compared PINCH expression between primary and
metastatic tumours in an orthotopic PDA animal model. We
subsequently correlated PINCH expression in primary human
paraffin-embedded PDA tumours, within both the tumour and
the peri-tumoral stroma cells, with disease stage and patient out-
comes. We hypothesized that PINCH protein expression would be
greater in the peri-tumoral stroma compared with tumour cells
and that the degree of PINCH protein expression would correlate
with a more invasive tumour or poorer patient prognosis.
Materials and methods
Cell culture
The human pancreatic cancer cell line AsPc1 was obtained from
the American Type Culture Collection (Rockville, MD, USA).
Cells were maintained in DMEM supplemented with 10% heat-
inactivated foetal bovine serum (Gibco, Inc., Grand Island, NY,
USA). Cells were cultured at 37 °C in a 5% CO2 incubator. The cell
line was transfected with and stably expressed red fluorescent
protein (RFP), as previously described.13
Orthotopic tumour production
Male nude mice (NCR-nu/nu) aged 4–6 weeks were utilized for
the orthotopic tumour model. All studies were conducted with the
approval and guidance of the University of Utah Institutional
Animal Care and Use Committee.
For the tumour induction surgery, mice were anesthetized with
isoflurane and the tail of the pancreas was exposed through a left
subcostal 4-mm incision into the peritoneal cavity.13 Mice received
a single sub-capsular injection of 1.5 ¥ 106 RFP-labelled AsPc1
cells suspended in 150 mL of serum-free media (DMEM). The
abdomen was closed using two interrupted 6–0 silk sutures
closing skin and muscle simultaneously. All procedures were
carried out utilizing a 12¥ Universal S3B microscope (Carl Zeiss,
Inc., Thornwood, NY, USA). Tumours were allowed to progress
for 8 weeks. At 8 weeks the animals were killed, the tumours
removed, sites of metastases noted, and metastatic tumours
removed. Primary and metastatic tumours were fixed in 10%
formalin, dehydrated, and embedded in paraffin.
Patients
Utilizing our institution’s clinical cancer research database
and tissue bank, we randomly identified 20 PDA patients’
paraffin-embedded block specimens and two normal controls.
Each patient had been diagnosed with pancreatic head adeno-
carcinoma and had undergone an en bloc resection with a
pancreaticoduodenectomy. The study pathologist analysed the
tissue blocks to determine which blocks represented the primary
tumours and tumour margins. New tissue slides for immuno-
histochemistry were made from these identified sections. With
the approval of the institutional review board, each patient’s chart
was reviewed for tumour staging, nodal status and margin status
at surgical resection, recurrence, and overall and disease-free
survival.
Immunohistochemistry
Immunohistochemical staining was performed on 4-mm thick
sections of formalin-fixed, paraffin-embedded tissue. Prior to
staining, heat-induced epitope retrieval (HIER) was performed in
citrate buffer, pH 6.0, in an electric pressure cooker (DC2000;
BioCare Medical LLC, Walnut Creek, CA, USA). Samples were
then stained for PINCH (BD Biosciences, Inc., San Jose, CA,
USA). Following incubation with the primary antibody, samples
were processed using a commercially available Alkaline Phos-
phatase Kit (Vector Laboratories, Inc., Burlingame, CA, USA). A
pathologist (author LE) analysed the samples to determine the
percentage of cells positively stained for PINCH, as well as the
intensity of the staining. The pathologist was blinded to tumour
location for the primary and metastatic tumours from the animal
PDA model. The index for the proportion of cells stained for
PINCH was defined by positive staining for PINCH of: (1) 0–25%;
(2) 26–50%; (3) 51–75%, and (4) 76–100%. Intensity of staining
for PINCH was scored as: (0) no staining; (1) mild staining; (2)
moderate staining, and (3) strong staining.
Statistics
In the analysis of animal tumours, a t-test was utilized to deter-
mine if there were differences in the proportion and intensity
indices for staining for PINCH in the primary orthotopic
tumour and peri-tumoral stroma compared with metastatic
tumours. A t-test was also utilized to determine if there were any
differences in the proportion and intensity indices for staining
for PINCH between the tumour and stroma cells within the
tumour.
In the analysis of human tumours, a t-test was utilized to deter-
mine if there were differences in the proportion and intensity
indices for staining for PINCH in the tumour cells compared with
the peri-tumoral stroma cells. A non-parametric Spearman’s rank
correlation was performed to determine whether staining corre-
lated with T and N tumour status. The final goal was to determine
if staining for PINCH in the tumour and peri-tumoral stroma
correlated with overall survival. The data were divided into groups
near the median and a likelihood ratio test using the Cox propor-
tional hazards model was performed. The estimated hazard ratio
(Cox model) and the median survival in each group (estimated
from the Kaplan–Meier curve) were also determined. Statistical
significance was set at P < 0.05.
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Results
PINCH expression in animal orthotopic PDA tumours
Nine of the 10 animals developed a primary orthotopic tumour.
All of these nine animals developed distant metastases (n = 19
metastases). The location of the metastases included the dia-
phragm (n = 6/19), mesentery (n = 5/19), liver (n = 4/19) and
peritoneal cavity (n = 4/19). There was constituent PINCH
expression in the mouse pancreas islet cells and acinar cells
(Fig. 1). The orthotopic tumour did not show significantly more
staining than the normal surrounding pancreas. The mouse
model tumours showed equivalent staining when the peri-
tumoral stroma cells were compared with the tumour cells
(Fig. 2).
Staining for PINCH, both by proportion and intensity of stain-
ing, was higher in the metastatic tumour cells compared with the
primary orthotopic tumour cells (Figs 1 and 2). By contrast with
the tumour cells, there were no differences in staining for PINCH
within the peri-tumoral stoma cells of the primary tumours
compared with the metastatic peri-tumoral stoma cells. There
were no differences in staining for PINCH between the various
metastatic sites, but the small sample size at each location limits
the significance of this finding.
PINCH expression in human PDA tumours
PINCH protein was constitutively expressed in the control pan-
creas, with greater staining in the islet cells than in the pancreatic
acinar cells (Fig. 3). Staining for PINCH was greater according to
both the proportion of stained cells and staining intensity in the
PDA peri-tumoral stroma cells compared with the tumour cells
(Fig. 4). All the patient samples demonstrated PINCH expression
in tumour and peri-tumoral stroma cells. In 70% (14/20) of cases,
>50% of the peri-tumoral stroma cells stained positive for
PINCH. By contrast, only 15% (3/20) of the tumour samples
showed positive staining for PINCH on >50% of the tumour cells.
The differences in staining between the tumour and peri-tumoral
(A) (B)
Figure 1 Light microscope images. (A) Mouse primary tumour immunohistochemically stained for PINCH, demonstrating strong constitutive
expression in the pancreas acinar cells (P). Both the tumour and peri-tumoral stroma cells of the primary tumour stain positive for PINCH.
(B) Mouse metastatic tumour cells stain to a greater degree than primary tumour cells. (Original magnification 200¥ in both images)
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Figure 2 Comparisons between tumour cells and tumour stroma cells in metastatic and primary tumours for (A) the proportion of cells
positively stained for PINCH and (B) staining intensity. The proportion of cells stained for PINCH and staining intensity were statistically
greater in tumour stroma compared with tumour cells. *P < 0.05; data are reported as mean  standard error
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stroma cells were also qualitatively evident by light microscopy
(Fig. 3).
PINCH expression correlated with disease stage
and patient outcomes
Patients
Demographic data for the 20 patients are presented in Table 1,
including gender, age, T stage, N stage, margin status and survival.
Patients included 12 women with an average age of 68 14 years
and eight men with an average age of 62  13 years. There were
no correlations between patient gender or age and staining for
PINCH. The majority of our patients had T3 tumours (n = 13).
According to American Joint Committee on Cancer (AJCC)
staging, one patient had stage I cancer, 10 had stage II cancer, and
nine had stage III cancer. Increased staining for PINCH in the
tumour cells, by both proportion and intensity of staining,
was correlated with higher T status (P < 0.05) (Table 2). PINCH
expression in the tumour cells was not statistically correlated with
N status. Additionally, staining for PINCH in the peri-tumoral
stroma was not statistically correlated with either T or N status.
Staining for PINCH and margin status were not statistically
correlated (P > 0.6; data not presented).
The data were also analysed to determine if there were any
correlations between survival and staining for PINCH. There was
a trend toward significance between the proportion of cells posi-
tively stained for PINCH (P = 0.07) and staining intensity (P =
0.06) in the peri-tumoral stroma cells and survival, with stronger
staining associated with poorer survival. The median survival was
884 days in subjects with low PINCH expression (n = 7) compared
with 337 days in subjects with high PINCH expression (n = 13),
with a hazard ratio of 2.3 (Fig. 5).
Discussion
The data from the present investigation support the hypothesis
that PINCH plays an important role in the progression of cancer.
Specifically, in the orthotopic animal model of PDA, we observed
greater PINCH expression in the invasive metastatic tumours
(A) (B)
Figure 3 Light microscope images. (A) Human control pancreas in which the islet cells (I) of the pancreas stain with a higher intensity
compared with the acinar cells (A). (B) Human pancreatic ductal adenocarcinoma tissue demonstrating staining for PINCH was stronger in
the peri-tumoral stroma cells (S) compared with the tumour cells (T). (Original magnification 400¥ in both images)
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Figure 4 Comparisons between tumour stroma cells and tumour cells for (A) the proportion of cells positively stained for PINCH and (B)
staining intensity. The proportion of cells stained for PINCH and staining intensity were statistically greater in tumour stroma compared with
tumour cells. *P < 0.05; data are reported as mean  standard error
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compared with the primary tumours. Secondly, within the human
samples analysed, higher T status and poorer survival correlated
with greater PINCH expression. Thus, in both the animal model
and patient population, PINCH expression correlated with a more
invasive and aggressive tumour phenotype.
Another interesting observation concerns the constituent
PINCH expression within the normal pancreas seen in both the
mouse PDA model and the human control samples. Although this
was not quantitatively determined, there did not appear to be
greater PINCH expression within the tumours compared with
the normal pancreas. This is by contrast with other cancers.
Wang-Rodriguez et al. confirmed increased expression of PINCH
protein in breast, prostate, lung and colorectal cancers relative to
healthy tissue.11 More recently, it has been shown that PINCH
Table 1 Patient demographic information
Patient Gender Age at
diagnosis,
years
T status N status Positive
pancreatic
margin
Positive retro-
peritoneal
margin
Survival,
days
1 F 77 2 1 No No 995
2 M 52 3 1 No No 267
3 M 65 1 0 No No 545
4 F 60 3 0 No No 1086
5 F 67 4 1 No Yes 157
6 F 35 3 1 No No 221
7 F 73 3 0 No No 457
8 M 77 3 1 No Yes 207
9 F 71 1 1 No Yes 921
10 M 37 3 1 No Yes 337
11 F 82 3 0 No No 2250
12 M 71 3 1 No No 399
13 F 73 3 0 No No 424
14 M 56 4 0 No No 884
15 F 80 3 0 No Yes 284
16 M 72 4 1 Yes Yes 222
17 F 73 3 1 No No 1700
18 M 66 1 Yes No 1923
19 F 82 3 1 Yes Yes 310
20 F 48 3 0 Yes No 314
F, female; M, male
Table 2 Spearman's rank correlation coefficients (rs) for PINCH
expression vs. tumour status (T) and nodal status (N)
Staining for PINCH T status N status
Tumour cells, proportion 0.493a 0.180
Tumour cells, intensity 0.477a 0.148
Tumour stroma, proportion -0.022 0.372
Tumour stroma, intensity 0.179 0.241
aStatistically positive correlation between PINCH expression and T status
(P < 0.05)
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Figure 5 Kaplan–Meier curve demonstrating the correlation between
PINCH expression in the stroma and survival. Individuals with lower
PINCH expression on average lived longer (P = 0.068). No patients
were lost to follow-up and thus no censor points are indicated on the
graph. The median survival was 884 days in subjects with low
PINCH (n = 7) compared with 337 days in subjects with high PINCH
(n = 13), with a hazard ratio of 2.3
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expression is greater in oesophageal and oral squamous cell
carcinoma, colorectal cancer and gliomas relative to normal
tissue.12,14–16 Taken together, the observation by others of greater
PINCH expression in the tumour, as well as our demonstration of
a correlation between PINCH expression and poorer patient
prognosis, suggest that PINCH expression may be an important
component of cancer progression in general.
Another important finding of the present investigation is that
PINCH expression appears to be stronger in the stroma cells
adjacent to the cancer cells in human PDA. PINCH expression in
the peri-tumoral stroma cells is roughly double that of the cancer
cells, in terms of both the proportion of cells stained and the
intensity of staining. PINCH expression is also demonstrated to a
greater degree in the peri-tumoral stroma tissue of other cancers
compared with the adjacent cancer cells.11,12,14–16 Evidence demon-
strating that the interactions between peri-tumoral stroma cells
and cancer cells may play an important part in the progression
and metastases of cancer is beginning to accumulate.2,3,6–8 This
may be even more important in PDA, as it is associated not only
with earlier incidences of metastases, but also with a much greater
desmoplastic response. Pancreatic stoma cells have been shown to
activate the ERK and AKT pathways and thus are strong promot-
ers of growth and invasion.2,3,8 These same pathways are also acti-
vated by PINCH.4,5,17 Thus PINCH in the peri-tumoral stroma
cells may be an important regulator of the growth and migration
of these cells, as well as adjacent cancer cells, and therefore a good
marker for determining the invasiveness of a tumour.
One interesting finding was that this differential expression
of PINCH between stroma and cancer cells did not exist in the
animal model. One possible explanation for this might be that the
cancer cells in the animal model were of human origin, whereas
the stromal cells were of mouse origin. Thus, expression differ-
ences may depend on species origin. Despite these differences,
PINCH expression still appeared to correlate with tumour pro-
gression in both the human samples and the animal model.
There are other pathways by which PINCH could influence
the transformation and progression of PDA. Specifically, PINCH
has a binding site for Nck-2 and integrin-linked kinase (ILK).4,5
Nck-2 is involved in growth factor mediating signalling, as well as
actin cytoskeleton remodelling.18 The interaction of PINCH and
Nck-2 directly links PINCH to the actin polymerization process
and therefore it is likely that PINCH plays a role in cytoskeleton
motility at cell–ECM adhesions. The binding of PINCH is also a
key regulator of ILK expression and is important for the local-
ization of ILK to the cell membrane.4,5 Disruption of the binding
of these two proteins results in alterations to cell motility, as
well as survival. In recognition of the role of PINCH protein
signalling in malignant transformation, many investigators
have hypothesized that PINCH protein expression would be
increased in more aggressive tumours. This has been docu-
mented in colorectal cancers, gliomas and oral epithelial
cancers.12,14–16 Specifically, PINCH expression is greater in higher-
grade gliomas independent of patient age, gender and tumour
size.14 Similar findings have been observed in oral epithelial
tumours, with greater PINCH expression in nodal metastases
relative to primary tumours, and in colorectal cancer, with
greater PINCH expression correlating to poorer patient progno-
sis.10,15 We confirmed a similar pattern whereby increased inva-
siveness or tumour aggressiveness was correlated with increased
PINCH expression in PDA. Several findings corroborate this
conclusion: firstly, in the murine orthotopic model, PINCH
expression was significantly higher in metastatic tumour tissue
than in primary tumours; secondly, in the human PDA tissues,
tumour T status correlated with increased PINCH expression,
and, finally, a trend toward increased PINCH expression in PDA
tumours with poorer patient survival is probably important. We
feel that the trend in survival failed to reach statistical signifi-
cance based on the small number of patients and the generally
poor prognosis of all patients with PDA. However, the human
data on T status and survival combined with the animal data on
metastatic tumours suggest that PINCH plays an important role
in the progression of PDA.
Conclusions
PINCH protein may function as a regulator or signal for ECM
invasion and cellular migration. Findings of increased PINCH
protein in more advanced stages of human PDA, as well as in
metastatic tumours from the animal model, support this hypo-
thesis. Additionally, the importance of the differential expression
of PINCH in the human tumour and stroma warrants further
evaluation.
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